Zdrowie i gospodarka · 15/06/2022

FDA Releases Draft Guidance for Industry on Quality Risk Management (Q9(R1))

The FDA is releasing a draft guidance for industry on Quality Risk Management (QRM), a framework for evaluating and managing quality risks in pharmaceutical products. The revised guidance aims to address areas of improvement, including reducing subjectivity in risk assessments and clarifying risk-based decision-making.